Tuberous sclerosis complex: the past and the future (Q38297624)

1 September 2017

1 reference

title

Tuberous sclerosis complex: the past and the future (English)

1 reference

1 September 2017

1 reference

1 reference

Liesbeth De Waele

1

1 reference

1 September 2017

Lieven Lagae

series ordinal

2

1 reference

1 September 2017

Djalila Mekahli

series ordinal

3

1 reference

1 September 2017

1 December 2014

1 reference

1 September 2017

1 reference

1 September 2017

30

1 reference

1 September 2017

10

1 reference

1 September 2017

1771-1780

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-014-3027-9

1 September 2017

0 references

cites work

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Tuberous sclerosis complex: renal imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Reduction of postembolization syndrome after ablation of renal angiomyolipoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Management of renal angiomyolipoma: analysis of 15 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Tuberous sclerosis complex: neurological, renal and pulmonary manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Clinical and molecular insights into tuberous sclerosis complex renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Renal cystic disease in the tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Glomerulocystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Tuberous sclerosis complex renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

A case of tuberous sclerosis complex that progressed to end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Epilepsy, Atherosclerosis, Myocardial Infarction, and Carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Causes of Death in Patients With Tuberous Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Subependymal giant cell tumors in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Subependymal Giant Cell Astrocytoma (SEGA) Treatment Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Advances in the management of subependymal giant cell astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The natural history of epilepsy in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Lymphangioleiomyomatosis screening in women with tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Incidence of tuberous sclerosis in patients with cardiac rhabdomyoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Diagnosis and management of fetal cardiac tumors: a multicenter experience and review of published reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Frequency and imaging appearance of hepatic angiomyolipomas in pediatric and adult patients with tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Mammalian target of rapamycin and the kidney. I. The signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Use of sirolimus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Autosomal dominant polycystic kidney disease: the last 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The radiological diagnosis and treatment of renal angiomyolipoma-current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Imaging of angiomyolipomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Subependymal giant cell astrocytoma: current concepts, management, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Surgical resection of subependymal giant cell astrocytomas (SEGAs) and changes in SEGA-related conditions: a US national claims database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Neurosurgical treatment of tuberous sclerosis complex lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Efficacy and safety of sirolimus in lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-3027-9

Renal angiomyolipoma: experience of 23 patients

21 January 2018

1 reference

12 December 2020

Rare association of renal angiomyolipoma and oncocytoma.

1 reference

12 December 2020

[Guidelines for the management of tuberous sclerosis complex renal disease]

1 reference

12 December 2020

Brain lesions in tuberous sclerosis complex. Review.

1 reference

12 December 2020

Renal lesion growth in children with tuberous sclerosis complex

1 reference

12 December 2020

"Macro" aneurysm in renal angiomyolipoma: two cases, with therapeutic embolization in one patient

1 reference

12 December 2020

Behavioral and cognitive aspects of tuberous sclerosis complex

1 reference

12 December 2020

Outcome analysis of 42 cases of renal angiomyolipoma

1 reference

12 December 2020

Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid

1 reference

12 December 2020

An epidemiological study of renal pathology in tuberous sclerosis complex

1 reference

12 December 2020

Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis

1 reference

12 December 2020

Morphologic features of renal oncocytoma: a light and electron microscopic study

1 reference

12 December 2020

Renal angiomyolipoma: growth followed up with CT and/or US

1 reference

12 December 2020

Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases

1 reference

12 December 2020

Subependymal giant cell astrocytoma in children with tuberous sclerosis

1 reference

12 December 2020

Diagnosis and management of renal angiomyolipoma

1 reference

12 December 2020

1 reference

12 December 2020

Managing epilepsy in tuberous sclerosis complex

1 reference

12 December 2020

Renal lesions in tuberous sclerosis

1 reference

12 December 2020

Comparison of T2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors

1 reference

12 December 2020

Symptomatic renal angiomyolipoma: report of 8 cases, 2 with spontaneous rupture

1 reference

12 December 2020

Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex

1 reference

12 December 2020

The natural history of renal angiomyolipoma

1 reference

12 December 2020

Outcome of patients with tuberous sclerosis after renal transplantation

1 reference

12 December 2020

Renal oncocytoma: origin from the collecting duct

1 reference

12 December 2020

Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex

1 reference

12 December 2020

Renal involvement in tuberous sclerosis

1 reference

12 December 2020

Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors

1 reference

12 December 2020

10.1007/S00467-014-3027-9

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference